{"name":"Crimson Biopharm Inc.","slug":"crimson-biopharm-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPN2lzOUM2dHhKRE5LR2ZQMHhzTmxaNk1YZnBpV0tQTUJlVGU0S3hoN2hmTVFmUFByeXlIMmYzRVpYejFjdUp4eWFYOTZ0M3BRa2xLUnNPeHQzUVIyTEJYeDNieExFQVRGZ1dBS1hwUGJYSTNYOG9JUWYxc1BFM2hpbkpXNVZQV2VGU0wwLVdnSjJHbXV3OVkxYTBNZ2hDSUk3dmRTUmVrb25wWkpISmkzblhNaGt6aHloN05nREFMVi1iOGlNV29zVzVnTm81N2oya1pBTElxeTMtbTNReWZrYjBUU05WUmNjQ1RQaTdtWFNzZzBCN2c?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPUGZEY2JIYWN3Y2dqeF9RYmtwWlBqa3Nxd1RodUNNOGI3THlfbzBLLVNGaUV1ZXZXMlkzTzluYmFBbzZnckdOSFd0NktuRUFLZkhvOWlwZWJTUkxSaDRfSkUyanFyWndvRnF3aTdJRjhIZWVabkE2NVJaZVNaaEJjeFc0dGIycnktSENVZTJOSGp0aFdxNzRNOEF5a0xOeGRJd01SLVBVTXR2bzNBU2xMYjhqVVMyU1lUOFE5Tzd6ellITkhqcUs3NHVwcEVOTUI5UHFZTTRiU3EtLU1OVkpOanZnVzVBa3lRaDA2X3hYUUtUM3ZqYWFScjFn?oc=5","date":"2026-03-21","type":"trial","source":"Barchart.com","summary":"Recurrent Glioblastoma Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight - Barchart.com","headline":"Recurrent Glioblastoma Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxQOGdNMTN1RElfTmhkU0xLTTZlV3Z4OTNEUjFyYjJLNzVjaFdUbDVHSjFrUXREZjAyLXF5clh4Q2x4U29Eb2loQkttODdYOVlUd2hFZkxPOEJDV0xIdEQ1OGZEaUQxMHVCR09NLS1Cd19QS0JxX3M5Q1I2RGtHQUpxTlZ2ZGpvUTNJdVo5ejQ5MGktaC1fdE85MnliWVc5eHpwdnZyMXhQU1d5N01MX3ItZktMLTd0bW5fcTVxNDVOeU44YnFSd3FjVWt6LXhhcXRadnAtRGlNYTR4MmlQbkNaY01fZTJLek1vWXdfRzZxV1FKSVNXV0RwbThRR21NNUlwbFExSG9CVnhuLVhiZFlkWHYwYXdJQzR3SGZSQzl6MS1HRjVZOTNKTTVzdm1RTmRwRVc0MWdrMTVMa2RQRTFaSlZncFNKVGJBYS1ibzdBNHI?oc=5","date":"2026-03-19","type":"pipeline","source":"Barchart.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Bar","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPc3ppc0ppZjIySF9aMFh6TS1WV1Z3VVI0c1EtNDU5SDhVc2thZGNZQ2pYUmFUdXQwSzhLd25nSHRjYXpESUI2RUlaREx4MU5FNU1lazJIS0FKVFpTWTItSWluMlB5YUNsUnJjbDE1bVJocjc2YnlxWFFjWlBhekpfcjln?oc=5","date":"2025-12-04","type":"pipeline","source":"The Harvard Crimson","summary":"As Cambridge Faces a Life Sciences Downturn, Startups Turn to a New Industry: Warfare - The Harvard Crimson","headline":"As Cambridge Faces a Life Sciences Downturn, Startups Turn to a New Industry: Warfare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQTG9CNlpXc3pWYmtINXhrUzRpMWl0NFk1Mm1IelNOVk9iMU1UZDZwc0RPQXZreFdPbjJRRjlMNFcxa1Nub2llM0JWZk1sb0VNTXl2eWh3ZjBfaHRXcXY0TnFnUXlFbS15WFFUTzhxRjdwYWZISUFtWkZhdXZ3WllraG9VQXdZT3VD?oc=5","date":"2025-11-24","type":"pipeline","source":"The Harvard Crimson","summary":"Facing Wary Investors and the Lure of Outsourcing, Cambridge Biotech Firms Turn Away From Basic Research - The Harvard Crimson","headline":"Facing Wary Investors and the Lure of Outsourcing, Cambridge Biotech Firms Turn Away From Basic Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBCMWdNamZFcnQxYnc3clM2Znd1RGRUc01LSFdLSzRmaEJQUk5wbHlOODBoU256OVFmNGV5dTR5alUtZklrdWtjX0dRYUdhNDNhMDA4U3hBZndmbXlpYzNtbG9xV2RzdzJNdjFLZzBYbGVZMzVJRkZv?oc=5","date":"2025-04-03","type":"regulatory","source":"The Harvard Crimson","summary":"FDA Layoffs, Funding Cuts Cast Shadow Over Biopharma Industry - The Harvard Crimson","headline":"FDA Layoffs, Funding Cuts Cast Shadow Over Biopharma Industry","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}